Patent · US Active

Ligand-conjugated monomers

US8404862B2 · kind B2 · utility

39Cited by

4References

40Claims

0Family size

Assignee

Alnylam Pharmaceuticals, Inc. · US

Inventors

Muthiah Manoharan · Carlsbad, US
Kallanthottathil G. Rajeev · Wayland, US
Venkitasamy Kesavan · Woburn, US

Key dates

Filing date	Jul 2, 2009
Grant date	Mar 26, 2013
Priority date	—
Expiry date	Sep 9, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/51
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates composition and methods for making and using chemically modified oligonucleotides agents for inhibiting gene expression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.